Literature DB >> 14534392

HIV risk reduction among African-American women who inject drugs: a randomized controlled trial.

Claire E Sterk1, Katherine P Theall, Kirk W Elifson, Daniel Kidder.   

Abstract

A community-based HIV intervention for African-American women who are active injection drug users (IDUs) was evaluated. Seventy-one women (aged 20-54 years) were randomly assigned to one of two enhanced gender- and culturally specific intervention conditions or to the NIDA standard condition. Substantial decreases (p<.001) were found in the frequency of drug use and the frequency of drug injection as well as in the sharing of injection works or water and the number of injections. Trading sex for drugs or money, having sex while high, as well as other sexual risk behaviors were also reduced significantly. Furthermore, women in both enhanced intervention conditions were more likely to reduce their drug-using and sexual risk behaviors than were women in the standard condition. Results indicate the value of including additional components in interventions designed to reduce the risk of infection with HIV among women who inject drugs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14534392     DOI: 10.1023/a:1022565524508

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  32 in total

1.  The effect of intimate partner violence on receptive syringe sharing among young female injection drug users: an analysis of mediation effects.

Authors:  Karla D Wagner; Sharon M Hudson; Mary H Latka; Steffanie A Strathdee; Hanne Thiede; Mary Ellen Mackesy-Amiti; Richard S Garfein
Journal:  AIDS Behav       Date:  2007-09-18

2.  Conceptualizing the Influence of Social Agents of Behavior Change: A Meta-Analysis of the Effectiveness of HIV-Prevention Interventionists for Different Groups.

Authors:  Marta R Durantini; Dolores Albarracín; Amy L Mitchell; Allison N Earl; Jeffrey C Gillette
Journal:  Psychol Bull       Date:  2006-03       Impact factor: 17.737

3.  Addressing the unique needs of African American women in HIV prevention.

Authors:  Nabila El-Bassel; Nathilee A Caldeira; Lesia M Ruglass; Louisa Gilbert
Journal:  Am J Public Health       Date:  2009-04-16       Impact factor: 9.308

Review 4.  The efficacy of behavioral interventions in reducing HIV risk behaviors and incident sexually transmitted diseases in heterosexual African Americans.

Authors:  Lynae Darbes; Nicole Crepaz; Cynthia Lyles; Gail Kennedy; George Rutherford
Journal:  AIDS       Date:  2008-06-19       Impact factor: 4.177

5.  Factors associated with positive HIV serostatus among women who use drugs: continued evidence for expanding factors of influence.

Authors:  Katherine P Theall; Claire E Sterk; Kirk W Elifson; Daniel Kidder
Journal:  Public Health Rep       Date:  2003 Sep-Oct       Impact factor: 2.792

Review 6.  Are cultural values and beliefs included in U.S. based HIV interventions?

Authors:  Gail E Wyatt; John K Williams; Arpana Gupta; Dominique Malebranche
Journal:  Prev Med       Date:  2011-08-22       Impact factor: 4.018

7.  Examining Risk for Frequent Cocaine Use: Focus on an African American Treatment Population.

Authors:  Tamika Chere Barkley Zapolski; Patrick Baldwin; Carl W Lejuez
Journal:  Subst Use Misuse       Date:  2016-04-21       Impact factor: 2.164

8.  Adapting an HIV/STDs Prevention Curriculum to Fit the Needs of Women With Alcohol Problems.

Authors:  Y Joon Choi; Diane M Langhorst; Sarah Meshberg-Cohen; Dace S Svikis
Journal:  J Soc Work Pract Addict       Date:  2011

Review 9.  Theoretical Foundations of Research Focused on HIV Prevention Among Substance-Involved Women: A Review of Observational and Intervention Studies.

Authors:  Judith D Auerbach; Laramie R Smith
Journal:  J Acquir Immune Defic Syndr       Date:  2015-06-01       Impact factor: 3.731

10.  HIV sexual risk behaviors and perception of risk among college students: implications for planning interventions.

Authors:  Adedeji S Adefuye; Titilayo C Abiona; Joseph A Balogun; Mainza Lukobo-Durrell
Journal:  BMC Public Health       Date:  2009-08-04       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.